Kopp Investment Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-3,806
| Closed | -$227K | – | 68 |
|
|
2017
Q3 | $227K | Buy |
3,806
+746
| +24% | +$44.5K | 0.21% | 59 |
|
|
2017
Q2 | $241K | Buy |
3,060
+10
| +0.3% | +$788 | 0.22% | 56 |
|
|
2017
Q1 | $253K | Sell |
3,050
-855
| -22% | -$70.9K | 0.25% | 56 |
|
|
2016
Q4 | $310K | Sell |
3,905
-405
| -9% | -$32.2K | 0.33% | 55 |
|
|
2016
Q3 | $302K | Buy |
+4,310
| New | +$302K | 0.3% | 55 |
|
|
2016
Q2 | – | Sell |
-5,388
| Closed | -$218K | – | 66 |
|
|
2016
Q1 | $218K | Buy |
5,388
+30
| +0.6% | +$1.21K | 0.12% | 61 |
|
|
2015
Q4 | $475K | Hold |
5,358
| – | – | 0.23% | 54 |
|
|
2015
Q3 | $397K | Buy |
5,358
+306
| +6% | +$22.7K | 0.21% | 53 |
|
|
2015
Q2 | $409K | Sell |
5,052
-6,873
| -58% | -$556K | 0.18% | 56 |
|
|
2015
Q1 | $500K | Buy |
+11,925
| New | +$500K | 0.22% | 57 |
|